Research prototype, not medical advice.

JAK inhibitors reduce the SASP, frailty and fat dysfunction in old mice.

Confidence
Established
Level of evidence
Laboratory mammals
Observed in
Mouse
Mission
Map of aging (12 hallmarks)
Concepts
Cellular senescenceJAK inhibitors (ruxolitinib)Senescence-associated secretory phenotype (SASP)

What the sources say

Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).

DirectionSourceWhere in the articleStatus
Supports JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age
Xu et al. · Proceedings of the National Academy of Sciences 2015
— Verified